Renal Supplement

Verify with FDA CVM →

11 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
11
Total Reports
5
Deaths Reported
4550.0%
Death Rate

Active Ingredients

Renal Supplement

Administration Routes

OralUnknown

Species Affected

Cat 9
Dog 2

Most Affected Breeds

Domestic Shorthair 6
Domestic Longhair 2
Collie - Border 1
Cat (unknown) 1
Terrier - Bull - American Pit 1

Most Reported Reactions

Death 5
Weight loss 3
Elevated alanine aminotransferase (ALT) 2
Behavioural disorder NOS 2
Urinary incontinence 2
Hind limb ataxia 2
Elevated blood urea nitrogen (BUN) 2
Collapse (see also Cardio-vascular and Systemic disorders) 2
Respiratory arrest 2
Deafness 2
Thickened ear canal(s) 2
Limb weakness 2

Outcome Breakdown

Died
5 (38.5%)
Outcome Unknown
4 (30.8%)
Ongoing
3 (23.1%)
Recovered/Normal
1 (7.7%)

Data Summary

Metric Value
Total adverse event reports 11
Reports involving death 5
Case-fatality rate (reported events) 4550.0%
Distinct species in reports 2
Distinct breeds in reports 5
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Renal Supplement Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 11 adverse event reports referencing Renal Supplement, including 5 reports in which the animal died — a 4550.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Renal Supplement. Reported administration routes include Oral, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Renal Supplement reports are Cat (9 reports), Dog (2 reports), with Cat accounting for the largest share. Within those species, Domestic Shorthair (6), Domestic Longhair (2), Collie - Border (1) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Renal Supplement are Death (5), Weight loss (3), Elevated alanine aminotransferase (ALT) (2), Behavioural disorder NOS (2). Of the 13 reports with a coded outcome, Died is the leading category at 38.5%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Renal Supplement.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial